213 related articles for article (PubMed ID: 7000348)
1. Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma.
Bryant BM; Wiltshaw E
Cancer Treat Rep; 1980; 64(4-5):689-92. PubMed ID: 7000348
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with vincristin, actinomycin D, cyclophosphamide and adriamycin in soft-part sarcoma].
Mori O; Takagi K; Kitagawa T; Harada M; Ogawa I
Gan No Rinsho; 1986 Aug; 32(9):998-1004. PubMed ID: 3747164
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas.
Pfeffer MR; Sulkes A; Biran S
Isr J Med Sci; 1988; 24(9-10):599-603. PubMed ID: 3204008
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for patients with soft tissue sarcoma.
Ozaki T; Sugihara S; Hamada M; Nakagawa Y; Inoue H
Hiroshima J Med Sci; 1993 Sep; 42(3):109-15. PubMed ID: 8253605
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy of soft tissue sarcoma].
Shinohara N; Yokoyama K
Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of soft tissue sarcomas in childhood and adolescence: results of the CWS-81 multicenter therapy study].
Koscielniak E; Treuner J; Jürgens H; Winkler K; Bürger D; Herbst M; Ritter J; Niethammer D; Müller-Weihrich S; Bernhard G
Klin Padiatr; 1991; 203(4):211-9. PubMed ID: 1942928
[TBL] [Abstract][Full Text] [Related]
7. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
8. The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group.
Bisogno G; Ferrari A; Bergeron C; Scagnellato A; Prete A; Alaggio R; Casanova M; D'Angelo P; Di Cataldo A; Carli M
Cancer; 2005 Apr; 103(8):1719-24. PubMed ID: 15754335
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
[TBL] [Abstract][Full Text] [Related]
10. Cyclical combination chemotherapeutic regimen in adult soft tissue sarcoma.
Dalley DN; Levi JA; Nesbitt RA; Tattersall MH; Woods RL; Fox RM; Aroney RS
Cancer Clin Trials; 1981; 4(2):163-5. PubMed ID: 7249252
[TBL] [Abstract][Full Text] [Related]
11. [Primary chemotherapy in soft tissue sarcomas considered inoperable].
Rouëssé J; Le Chevalier T; Contesso G; Sarrazin D; Amiel JL; Sevin D; Carde P; Génin J
Sem Hop; 1983 May; 59(19):1441-4. PubMed ID: 6310758
[TBL] [Abstract][Full Text] [Related]
12. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
Bui B; Chauvergne J; Durand M; Brunet R
Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
[TBL] [Abstract][Full Text] [Related]
13. [Soft tissue sarcoma: postoperative chemotherapy].
Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
[TBL] [Abstract][Full Text] [Related]
14. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy of sarcoma. A comparison of three regimens.
Subramanian S; Wiltshaw E
Lancet; 1978 Apr; 1(8066):683-6. PubMed ID: 76224
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma.
Pápai Z; Bodoky G; Szántó J; Poller I; Rahóty P; Eckhardt S; Láng I; Szendroi M
Cancer; 2000 Jul; 89(1):177-80. PubMed ID: 10897015
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy of malignant soft tissue tumors].
Hossfeld DK; Lempidakis S; Seeber S
Chirurg; 1983 Oct; 54(10):649-51. PubMed ID: 6678721
[No Abstract] [Full Text] [Related]
18. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
Schütte J; Kellner R; Seeber S
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
[TBL] [Abstract][Full Text] [Related]
19. [A combination chemotherapy with adriamycin, cyclophosphamide and DTIC (ACD) for advanced adult soft part sarcoma].
Ikeda K; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Usui N; Nakada H; Adachi K; Okada Y
Gan To Kagaku Ryoho; 1984 Feb; 11(2):235-9. PubMed ID: 6696459
[TBL] [Abstract][Full Text] [Related]
20. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
